A Study of the Effect of Diltiazem on the Plasma Levels of Nemtabrutinib (MK-1026-022)
Clinical trial NCT07232589 · COMPLETED
Trial details
- NCT number
- NCT07232589
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-08
- Primary completion
- 2026-05-04
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.